Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Nonpeptide mimic of bradykinin with long-acting properties.

Aramori I, Zenkoh J, Morikawa N, Asano M, Hatori C, Sawai H, Kayakiri H, Satoh S, Inoue T, Abe Y, Sawada Y, Mizutani T, Inamura N, Iwami M, Nakahara K, Kojo H, Oku T, Notsu Y.

Immunopharmacology. 1999 Dec;45(1-3):185-90.

PMID:
10615010
2.

Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor.

Aramori I, Zenkoh J, Morikawa N, Asano M, Hatori C, Sawai H, Kayakiri H, Satoh S, Inoue T, Abe Y, Sawada Y, Mizutani T, Inamura N, Nakahara K, Kojo H, Oku T, Notsu Y.

Mol Pharmacol. 1997 Jul;52(1):16-20.

PMID:
9224807
3.

Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.

Asano M, Hatori C, Sawai H, Johki S, Inamura N, Kayakiri H, Satoh S, Abe Y, Inoue T, Sawada Y, Mizutani T, Oku T, Nakahara K.

Br J Pharmacol. 1998 Jun;124(3):441-6.

4.

Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo.

Hayashi I, Ishihara K, Kumagai Y, Majima M.

Br J Pharmacol. 2001 Aug;133(8):1296-306.

5.

Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.

Meini S, Patacchini R, Lecci A, Quartara L, Maggi CA.

Eur J Pharmacol. 2000 Dec 8;409(2):185-94.

PMID:
11104833
6.

The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.

Bellucci F, Meini S, Cucchi P, Catalani C, Giuliani S, Zappitelli S, Rotondaro L, Quartara L, Giolitti A, Maggi CA.

Eur J Pharmacol. 2004 May 3;491(2-3):121-5.

PMID:
15140628
7.
8.

A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis.

Bellucci F, Meini S, Cucchi P, Catalani C, Reichert W, Zappitelli S, Rotondaro L, Quartara L, Giolitti A, Maggi CA.

Br J Pharmacol. 2003 Oct;140(3):500-6. Epub 2003 Aug 26.

9.

MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.

Cucchi P, Meini S, Bressan A, Catalani C, Bellucci F, Santicioli P, Lecci A, Faiella A, Rotondaro L, Giuliani S, Giolitti A, Quartara L, Maggi CA.

Eur J Pharmacol. 2005 Dec 28;528(1-3):7-16. Epub 2005 Dec 1.

PMID:
16324696
10.

Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657.

Aramori I, Zenkoh J, Morikawa N, O'Donnell N, Asano M, Nakamura K, Iwami M, Kojo H, Notsu Y.

Mol Pharmacol. 1997 Feb;51(2):171-6.

PMID:
9203620
11.

The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.

Asano M, Inamura N, Hatori C, Sawai H, Fujiwara T, Katayama A, Kayakiri H, Satoh S, Abe Y, Inoue T, Sawada Y, Nakahara K, Oku T, Okuhara M.

Br J Pharmacol. 1997 Feb;120(4):617-24.

12.

Mouse paw edema induced by a novel bradykinin agonist and its inhibition by B2-antagonists.

Ueno A, Naraba H, Oh-ishi S.

Jpn J Pharmacol. 1998 Sep;78(1):109-11.

13.

Bradykinin B2 and GPR100 receptors: a paradigm for receptor signal transduction pharmacology.

Meini S, Bellucci F, Cucchi P, Giuliani S, Quartara L, Giolitti A, Zappitelli S, Rotondaro L, Boels K, Maggi CA.

Br J Pharmacol. 2004 Dec;143(8):938-41. Epub 2004 Nov 15.

14.
15.

FR190997, a novel bradykinin B2 agonist, expresses longer action than bradykinin in paw edema formation and hypotensive response.

Ueno A, Naraba H, Kojima F, Morita E, Oh-ishi S.

Immunopharmacology. 1999 Dec;45(1-3):89-93.

PMID:
10614995
16.

Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.

Paquet JL, Luccarini JM, Fouchet C, DefrĂȘne E, Loillier B, Robert C, BĂ©lichard P, Cremers B, Pruneau D.

Br J Pharmacol. 1999 Mar;126(5):1083-90.

17.

A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.

Abe Y, Kayakiri H, Satoh S, Inoue T, Sawada Y, Inamura N, Asano M, Aramori I, Hatori C, Sawai H, Oku T, Tanaka H.

J Med Chem. 1998 Nov 5;41(23):4587-98.

PMID:
9804698
18.

Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344.

Inamura N, Asano M, Hatori C, Sawai H, Hirosumi J, Fujiwara T, Kayakiri H, Satoh S, Abe Y, Inoue T, Sawada Y, Oku T, Nakahara K.

Eur J Pharmacol. 1997 Aug 20;333(1):79-86.

PMID:
9311664
19.

Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).

Gobeil F Jr, Montagne M, Inamura N, Regoli D.

Immunopharmacology. 1999 Sep;43(2-3):179-85.

PMID:
10596851
20.

A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety.

Abe Y, Kayakiri H, Satoh S, Inoue T, Sawada Y, Inamura N, Asano M, Aramori I, Hatori C, Sawai H, Oku T, Tanaka H.

J Med Chem. 1998 Oct 8;41(21):4062-79.

PMID:
9767643

Supplemental Content

Support Center